ArticlePharmaceutics2021

Pheophorbide A and Paclitaxel Bioresponsive Nanoparticles as Double-Punch Platform for Cancer Therapy.

Francesca Moret et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.